Virtus Biotech Clinical Trials ETF
BBC
Closed
$43.05
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
BBC was created on 2014-12-16 by Virtus. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 44.67m in AUM and 123 holdings. BBC tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials.
Company
Virtus
Asset class
Equity
Inception date
2014
Investment segment
Health Care
ISIN
US26923G3011
Website
Key stats
Open
$42.36
Volume
6.57K
AUM
$40.06M
Prev. close
$43.03
Expense ratio
0.65%
P/E
0.00
$42.29
Day’s Range
$43.38
$36.22
52W Range
$48.18
What’s in the fund
2
Total sectors
Health Care
98.21%
Others
1.79%
Returns
Performance
_
Difference
_
Virtus Biotech Clinical Trials ETF
Dec
29
Dividends
The last payment date was Dec 29, 2025
Div. per Share
$0.66
Div. Yield
1.52%
Div. Growth YoY
173.70%
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply